Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Crosbys Drugs Inc
483
•Crosbys Drugs Inc•September 16, 2016

Crosbys Drugs Inc – FDA 483, Sep 16, 2016

Record Details

This FDA Form 483, issued to Sherrie L. Cohen-Merchant, Owner of Crosbys Drugs Inc, a producer of sterile drugs located at 2609 N High St, Columbus, OH, was conducted from September 12-16, 2016. The inspection revealed eight observations concerning the facility's sterile drug production.

Observation 1 noted a lack of established and followed procedures to prevent microbiological contamination, citing an employee touching an uncovered container with bare hands during Tri-Mix production, absence of smoke studies for the ISO 5 hood, and no data for process simulation tests.

Observation 2 indicated that personnel clothing was inappropriate, with non-sterile gowns and face coverings being reused multiple times.

Observation 3 stated that drug product containers and closures were not properly cleaned and sterilized to remove pyrogenic properties, specifically mentioning equipment cleaned with non-depyrogenated methods.

Observation 4 highlighted that the flow of components and in-process materials was not designed to prevent contamination, as equipment was not disinfected when moved between clean rooms.

Observation 5 detailed deficiencies in environmental monitoring within aseptic processing areas, including infrequent particulate and viable air sampling, infrequent fingertip plating, and lack of historical monitoring data.

Observation 6 found that container closure systems lacked data to support protection against external factors, specifically for alprostadil containers.

Observation 7 reported that sterile and pyrogen-free drug products, including Tri-

Company
Crosbys Drugs Inc
Inspection date
September 16, 2016
Product type
Drugs
Office
Cincinnati District Office
Person
  • Matthew B. Casale ( Investigator )
View Company Profile

ID · d943f364-4ea8-49c4-8e77-fe68d76ffcc0

Violation Codes1
21 CFR 331(c)

Full citation text and observation details available on the Dashboard.

Other documents for Crosbys Drugs Inc
  • 483 - 2021-09-30September 30, 2021
  • WARNING_LETTER - 2016-09-16September 16, 2016

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Crosbys Drugs Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.